Daily news & Analysis
For breaking news and analysis throughout the day, visit HealthLeadersMedia.com or add the RSS Feed of our Daily News & Analysis.
By: Janice Simmons, for HealthLeaders Media, October 15, 2009
Senate Majority Leader Harry Reid (D-NV) is pushing to repeal health insurance and medical malpractice insurance companies' antitrust exemption, which is part of the McCarran-Ferguson Act. As a co-sponsor of a bill (S. 1681) to repeal the 1945 law, Reid appeared as a witness at a hearing on the legislation before the Senate Judiciary Committee Wednesday.
More Analysis »
By: Cheryl Clark, for HealthLeaders Media, October 15, 2009
New guidance from the federal Centers for Disease Control and Prevention that all healthcare workers who come in contact with patients suspected of having H1N1 wear N95 respirators is being met with dismay by providers who specialize in infection control.
More Analysis »
By: Scott Wallask, for HealthLeaders Media, October 14, 2009
Although it may be perceived as a chore, there's a sizeable payoff to executives meeting with frontline clinicians now to assure them of their safety during an H1N1 swine flu outbreak.
More Analysis »
By: Cheryl Clark, for HealthLeaders Media, October 15, 2009
California Gov. Arnold Schwarzenegger is illegally exacerbating an "imminent crisis in healthcare" because forced worker furloughs are delaying the state Medical Board's approval of applications from 7,200 new doctors, says a lawsuit filed by the California Medical Association.
More Analysis »
By: Elyas Bakhtiari, for HealthLeaders Magazine, October 8, 2009
The nation's emergency departments are feeling the effects of the economic downturn, but innovations in patient throughput and other strategies offer hope for a beleaguered system.
More Analysis »
By: Janice Simmons, for HealthLeaders Media, October 15, 2009
In a settlement announced Wednesday, the Federal Trade Commission said it has resolved its ongoing investigation of Pfizer's proposed $68 billion acquisition of Wyeth and concluded that the transaction does not raise anticompetitive concerns in any human health product markets. However, to "preserve competition in multiple American markets" for animal pharmaceuticals and vaccines, "significant divestitures" need to take place, the FTC said.
More Analysis »
By: Dom Nicastro, for HealthLeaders Media, October 14, 2009
Revenue cycle managers constantly search for the perfect benchmark information to compare their team's work with others, but don't search too hard.
More Analysis »
By: John Commins, for HealthLeaders Media, October 15, 2009
Healthways, Inc., the Nashville-based population health management company, announced Wednesday that it has purchased HealthHonors, a behavioral economic company based in Braintree, MA, for $14.7 million. "Just as Healthways has led the industry in applying behavior change science, now we will lead the market in offering scientifically based incentive programs," says Ben R. Leedle, Jr., Healthways' CEO.
More Analysis »
By: Les Masterson, for HealthLeaders Media, October 14, 2009
Though businesses are transferring more health costs onto employees, health insurers and employers have to be careful not to pass too many costs onto the consumer.
More Analysis »
By: Cheryl Clark, for HealthLeaders Media, October 14, 2009
There is no uniform accreditation or certification process to guarantee the competence of language interpreters in healthcare settings. But that may soon change.
More Analysis »
By: Gienna Shaw, for HealthLeaders Media, October 14, 2009
This week, I have a real-life example of why patient experience matters—perhaps even more than loyalty, location, quality, cost, or brand awareness.
More Analysis »
|
